Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

COLFAX CORPORATION

(CFX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Colfax : Schedules Third Quarter 2021 Earnings Release and Conference Call

10/18/2021 | 10:46am EST

WILMINGTON, DE, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced that it will issue a press release providing financial results for the third quarter of 2021 on the morning of Thursday, November 4, 2021. The Company will hold a conference call to discuss these results beginning at 8:00 a.m. Eastern on that day, which will be open to the public by calling +1-888-771-4371 (U.S. callers) and +1-847-585-4405 (International callers) and referencing the conference ID number 50243903 and through webcast via Colfax’s website www.colfaxcorp.com under the “Investors” section.

Colfax’s financial results press release and supplemental information referenced on the call, if any, for the third quarter of 2021 will be available under the “Investors” section of Colfax’s website prior to the conference call. A link to a replay of the call will also be available on the Colfax website later that day.

About Colfax Corporation

Colfax Corporation (NYSE: CFX) is a leading diversified technology company that provides orthopedic and fabrication technology products and services to customers around the world, principally under the DJO and ESAB brands. The Company uses its Colfax Business System (“CBS”), a comprehensive set of tools and processes, to create superior value for customers, shareholders and associates. In March of 2021, Colfax announced its intention to separate into two independent and public companies, which is targeted to be completed in the first quarter of 2022 to accelerate strategic momentum and unlock additional value creation potential; one business will focus on specialty medical technologies and the other on fabrication technologies. For more information about Colfax and our separation activities, please visit www.colfaxcorp.com.



All news about COLFAX CORPORATION
11/11INSIDER SELL : Colfax
MT
11/09UBS Lifts Price Target on Colfax to $60 From $57; Buy Rating Kept
MT
11/05KeyBanc Adjusts Price Target on Colfax to $60 from $57, Keeps Overweight Rating
MT
11/05Deutsche Bank Lifts Colfax PT to $55 From $48, Maintains Hold Rating
MT
11/04Colfax Posts Higher Q3 Earnings, Net Sales
MT
11/04COLFAX : Q3 Earnings Snapshot
AQ
11/04Colfax Corporation Announces Third Quarter 2021 Results - Form 8-K
PU
11/04COLFAX CORP Management's Discussion and Analysis of Financial Condition and Results of..
AQ
11/04Colfax Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended..
CI
11/04NORTH AMERICAN MORNING BRIEFING : Stocks Futures -3-
DJ
More news
Analyst Recommendations on COLFAX CORPORATION
More recommendations
Financials (USD)
Sales 2021 3 841 M - -
Net income 2021 134 M - -
Net Debt 2021 1 350 M - -
P/E ratio 2021 53,9x
Yield 2021 -
Capitalization 7 507 M 7 507 M -
EV / Sales 2021 2,31x
EV / Sales 2022 2,03x
Nbr of Employees 15 400
Free-Float 88,8%
Chart COLFAX CORPORATION
Duration : Period :
Colfax Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends COLFAX CORPORATION
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Last Close Price 48,50 $
Average target price 56,88 $
Spread / Average Target 17,3%
EPS Revisions
Managers and Directors
Matthew L. Trerotola President, Chief Executive Officer & Director
Christopher Michael Hix Chief Financial Officer & Executive VP-Finance
Mitchell P. Rales Non-Executive Chairman
Patrick William Allender Independent Director
Thomas Sinnickson Gayner Independent Director
Sector and Competitors
1st jan.Capi. (M$)
COLFAX CORPORATION26.83%7 507
ATLAS COPCO AB31.51%70 385
PARKER-HANNIFIN CORPORATION13.67%39 975
FANUC CORPORATION-9.17%38 980
TECHTRONIC INDUSTRIES COMPANY LIMITED47.11%38 270
SANDVIK AB12.97%31 321